McCormick P, OGrady M, De Gascun C, Lambert J, Crosbie O, McKiernan S
Ir J Med Sci. 2024; 193(3):1257-1260.
PMID: 38285072
PMC: 11128382.
DOI: 10.1007/s11845-023-03604-2.
Connolly S, Avramovic G, Cullen W, McHugh T, OConnor E, Mc Combe G
Ir J Med Sci. 2020; 190(2):587-595.
PMID: 32761548
DOI: 10.1007/s11845-020-02324-1.
Mahmud S, Mumtaz G, Chemaitelly H, Al Kanaani Z, Kouyoumjian S, Hermez J
Addiction. 2020; 115(7):1244-1262.
PMID: 32009283
PMC: 7318323.
DOI: 10.1111/add.14944.
Wuytack F, Lutje V, Jakobsen J, Weiss K, Flanagan P, Gethin G
HRB Open Res. 2020; 1:10.
PMID: 32002504
PMC: 6973529.
DOI: 10.12688/hrbopenres.12791.1.
Crowley D, Murtagh R, Cullen W, Lambert J, McHugh T, Van Hout M
BMC Infect Dis. 2019; 19(1):702.
PMID: 31395032
PMC: 6686252.
DOI: 10.1186/s12879-019-4218-6.
Opt-out bloodborne virus screening: a cross-sectional observational study in an acute medical unit.
Allen N, Faherty C, Davies A, Lyons A, Scarry M, Bohan Keane M
BMJ Open. 2019; 9(7):e022777.
PMID: 31315851
PMC: 6661585.
DOI: 10.1136/bmjopen-2018-022777.
Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.
Crowley D, Van Hout M, Murphy C, Kelly E, Lambert J, Cullen W
BMC Nurs. 2019; 18:23.
PMID: 31210751
PMC: 6567378.
DOI: 10.1186/s12912-019-0347-x.
The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
Crowley D, Lambert J, Betts-Symonds G, Cullen W, Keevans M, Kelly E
Euro Surveill. 2019; 24(14).
PMID: 30968825
PMC: 6462789.
DOI: 10.2807/1560-7917.ES.2019.24.14.1800369.
'HepCheck Dublin': an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care.
Lambert J, Murtagh R, Menezes D, OCarroll A, Murphy C, Cullen W
BMC Infect Dis. 2019; 19(1):128.
PMID: 30732573
PMC: 6367728.
DOI: 10.1186/s12879-019-3748-2.
Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice.
Delargy I, Crowley D, Van Hout M
Harm Reduct J. 2019; 16(1):5.
PMID: 30654803
PMC: 6337760.
DOI: 10.1186/s12954-018-0272-4.
Incidence of hepatitis C among people who inject drugs in Ireland.
Carew A, Murphy N, Long J, Hunter K, Lyons S, Walsh C
Hepatol Med Policy. 2018; 2:7.
PMID: 30288320
PMC: 6171004.
DOI: 10.1186/s41124-017-0024-1.
Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.
Garvey P, OGrady B, Franzoni G, Bolger M, Irwin Crosby K, Connell J
Euro Surveill. 2017; 22(30).
PMID: 28797323
PMC: 5553053.
DOI: 10.2807/1560-7917.ES.2017.22.30.30579.
Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.
Crowley D, Cullen W, Laird E, Lambert J, Hugh T, Murphy C
J Transl Int Med. 2017; 5(2):112-119.
PMID: 28721344
PMC: 5506411.
DOI: 10.1515/jtim-2017-0017.
Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.
Gray E, Pasta D, Norris S, OLeary A
BMC Health Serv Res. 2017; 17(1):288.
PMID: 28424064
PMC: 5395881.
DOI: 10.1186/s12913-017-2188-1.
Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study.
OKelly M, Byrne D, Naughten E, Bergin C, Williams C
Br J Gen Pract. 2016; 66(647):e392-6.
PMID: 27114211
PMC: 4871304.
DOI: 10.3399/bjgp16X685225.
Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.
OConnell S, Lillis D, Cotter A, ODea S, Tuite H, Fleming C
PLoS One. 2016; 11(3):e0150546.
PMID: 26967517
PMC: 4788349.
DOI: 10.1371/journal.pone.0150546.
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.
Kieran J, Norris S, OLeary A, Walsh C, Merriman R, Houlihan D
BMC Infect Dis. 2015; 15:471.
PMID: 26503519
PMC: 4624167.
DOI: 10.1186/s12879-015-1208-1.
The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis.
Conway R, Doran M, OShea F, Crowley B, Cunnane G
Clin Rheumatol. 2014; 33(12):1823-7.
PMID: 24728880
DOI: 10.1007/s10067-014-2612-4.